Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neu...
Saved in:
Published in | PloS one Vol. 11; no. 6; p. e0157160 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
13.06.2016
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART).
We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions.
Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06).
Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. |
---|---|
AbstractList | Objective
Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART).
Design and Methods
We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions.
Results
Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06).
Conclusions
Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. OBJECTIVEAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART).DESIGN AND METHODSWe selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions.RESULTSGeometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06).CONCLUSIONSMild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). Design and Methods We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Results Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Conclusions Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p<0.001) but not in the NCN group (r = -0.13; p = 0.3). Additionally, a trend towards higher NFL was seen in the NCI group (p = 0.06). Mild HAND was associated with increased intrathecal immune activation, and the correlation between neopterin and NFL found in NCI subjects indicates an association between neurocognitive impairment, CNS inflammation and neuronal damage. Together these findings suggest that NCI despite ART may represent an active pathological process within the CNS that needs further characterization in prospective studies. Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients on antiretroviral therapy (ART). We examined the relationship between mild HAND and CSF neurofilament light protein (NFL), a biomarker of neuronal injury; and CSF neopterin, a biomarker of CNS immunoactivation, in virally suppressed patients on antiretroviral therapy (ART). We selected 99 subjects on suppressive ART followed longitudinally from the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study. Based on standardized comprehensive neurocognitive performance (NP) testing, subjects were classified as neurocognitively normal (NCN; n = 29) or impaired (NCI; n = 70). The NCI group included subjects with asymptomatic (ANI; n = 37) or mild (MND; n = 33) HAND. CSF biomarkers were analyzed on two occasions. Geometric mean CSF neopterin was 25% higher in the NCI group (p = 0.04) and NFL and neopterin were significantly correlated within the NCI group (r = 0.30; p |
Audience | Academic |
Author | Nilsson, Staffan Marcotte, Thomas D. Price, Richard W. Letendre, Scott L. Gisslén, Magnus Heaton, Robert K. Fuchs, Dietmar Zetterberg, Henrik Franklin, Donald Edén, Arvid Grant, Igor |
AuthorAffiliation | 4 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden 5 Institute of Neurology, University College London, London, United Kingdom 7 Department of Neurology, University of California San Francisco, San Francisco, California, United States of America 1 Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden UNSW Australia, AUSTRALIA 2 Department of Psychiatry, University of California San Diego, San Diego, California, United States of America 3 Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden 6 Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria |
AuthorAffiliation_xml | – name: 7 Department of Neurology, University of California San Francisco, San Francisco, California, United States of America – name: 1 Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden – name: 2 Department of Psychiatry, University of California San Diego, San Diego, California, United States of America – name: 3 Mathematical Sciences, Chalmers University of Technology, Gothenburg, Sweden – name: 6 Division of Biological Chemistry, Biocenter, Innsbruck Medical University, Innsbruck, Austria – name: 5 Institute of Neurology, University College London, London, United Kingdom – name: UNSW Australia, AUSTRALIA – name: 4 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden |
Author_xml | – sequence: 1 givenname: Arvid surname: Edén fullname: Edén, Arvid – sequence: 2 givenname: Thomas D. surname: Marcotte fullname: Marcotte, Thomas D. – sequence: 3 givenname: Robert K. surname: Heaton fullname: Heaton, Robert K. – sequence: 4 givenname: Staffan surname: Nilsson fullname: Nilsson, Staffan – sequence: 5 givenname: Henrik surname: Zetterberg fullname: Zetterberg, Henrik – sequence: 6 givenname: Dietmar surname: Fuchs fullname: Fuchs, Dietmar – sequence: 7 givenname: Donald surname: Franklin fullname: Franklin, Donald – sequence: 8 givenname: Richard W. surname: Price fullname: Price, Richard W. – sequence: 9 givenname: Igor surname: Grant fullname: Grant, Igor – sequence: 10 givenname: Scott L. surname: Letendre fullname: Letendre, Scott L. – sequence: 11 givenname: Magnus surname: Gisslén fullname: Gisslén, Magnus |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27295036$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/240034$$DView record from Swedish Publication Index https://research.chalmers.se/publication/240034$$DView record from Swedish Publication Index |
BookMark | eNqNk91r1TAYxoso7kP_A9GCIHpxjknTJI0XwhjqDgwnTncb0vRtm9E2NUk399-b7pzJzpgf9KLt29_z0Dwvz17ycLADJMkzjJaYcPz23E5uUN1yjOMlwpRjhh4ku1iQbMEyRB7eet5J9rw_R4iSgrHHyU7GM0ERYbtJWA3agfJQpashOBVa0KpLV30_DZAe6GAuVDB2SM2Qnhmnuu4qPZ3G0YGfNUerswWOyhp0iK9fIgtD8OmlCW36GSZntW0GE10geo7KuD5-f5I8qlXn4enmvp98__jh2-HR4vjk0-rw4HihCyLCAipeYw24pIpwqDKGgSCmFVGaMo11iRVVHIlaZFmldYTzLNe6LgsOuqY12U9erH3Hznq5CcxLzAXLckoEj8RqTVRWncvRmV65K2mVkdcD6xqpXDC6A8kZIITLCghjea2EYERTrsqKiqJmDEWv07WXv4RxKrfcYlygnG6lblXXg_PSg8RCYSbqQmKMuMxVzmVRaSyLoswJAlzEUXRd_NG1mUYZR800u2U5QmTm32_OPJU9VBrmrXZbsu0vg2llYy9kLhBlnEWD1xsDZ39M4IPsjdfQdWoAO8X0ClSwgmYE_xvlgmeUUDKH8_IOev86NlSjYuJmqG38RT2byoOcUoRJzkSklvdQ8aqgNzrWoTZxviV4syWITICfoVGT93J1-vX_2ZOzbfbVLbYF1YXW226aC-O3wee3l_J7Gzc9jMC7NaCd9d5BLbUJ18WLRzOdxEjOpb8JTc6ll5vSR3F-R3zj_1fZL1wCXCk |
CitedBy_id | crossref_primary_10_1080_14737159_2017_1341313 crossref_primary_10_1186_s12974_019_1404_9 crossref_primary_10_1093_cid_ciad265 crossref_primary_10_1007_s13365_016_0495_7 crossref_primary_10_1021_jasms_3c00276 crossref_primary_10_1007_s13365_020_00877_6 crossref_primary_10_1093_infdis_jix662 crossref_primary_10_1007_s13365_023_01116_4 crossref_primary_10_1128_spectrum_01975_21 crossref_primary_10_3389_fimmu_2020_583934 crossref_primary_10_3390_v14091997 crossref_primary_10_1097_QAD_0000000000002300 crossref_primary_10_1097_QAD_0000000000002980 crossref_primary_10_1007_s13365_018_0696_3 crossref_primary_10_1097_QAD_0000000000002264 crossref_primary_10_3389_fmicb_2018_03352 crossref_primary_10_1097_COH_0000000000000433 crossref_primary_10_1097_QAD_0000000000002270 crossref_primary_10_1128_mBio_00602_20 crossref_primary_10_3390_ijms232113328 crossref_primary_10_1007_s13365_019_00735_0 crossref_primary_10_1093_ofid_ofad064 crossref_primary_10_1007_s11908_017_0606_5 crossref_primary_10_3390_v15020378 crossref_primary_10_1172_jci_insight_121718 crossref_primary_10_3390_ijms17101639 crossref_primary_10_1111_joim_13594 crossref_primary_10_1007_s11904_019_00420_1 crossref_primary_10_1097_QAI_0000000000002714 crossref_primary_10_3390_v15122410 crossref_primary_10_1007_s11904_021_00581_y crossref_primary_10_1007_s13365_018_0661_1 crossref_primary_10_1136_bmjopen_2022_070693 crossref_primary_10_1093_jac_dkaa473 crossref_primary_10_1097_QAD_0000000000002076 crossref_primary_10_1007_s13365_021_01047_y crossref_primary_10_1186_s12974_019_1617_y crossref_primary_10_1097_WCO_0000000000000807 crossref_primary_10_3390_life14040508 crossref_primary_10_1007_s11011_019_00452_x crossref_primary_10_1212_NXI_0000000000000512 crossref_primary_10_1007_s12035_018_1329_9 crossref_primary_10_3390_v15030700 crossref_primary_10_1016_j_ebiom_2019_10_029 crossref_primary_10_1093_infdis_jiac138 crossref_primary_10_1371_journal_pone_0250987 crossref_primary_10_1093_infdis_jiae555 crossref_primary_10_1038_s41582_023_00813_2 crossref_primary_10_1128_mBio_00591_19 crossref_primary_10_1080_1040841X_2022_2146481 crossref_primary_10_1093_cid_cix473 crossref_primary_10_1097_QAD_0000000000002326 crossref_primary_10_1016_j_jneuroim_2020_577246 crossref_primary_10_1093_infdis_jiac370 crossref_primary_10_1097_QAD_0000000000001950 crossref_primary_10_1097_QAD_0000000000002121 crossref_primary_10_1007_s13365_024_01200_3 crossref_primary_10_1080_13554794_2018_1530362 crossref_primary_10_1016_j_jneuroim_2021_577649 crossref_primary_10_1016_j_phrs_2023_106898 crossref_primary_10_1038_s41582_023_00879_y crossref_primary_10_1097_MD_0000000000009969 crossref_primary_10_1007_s40265_016_0678_9 crossref_primary_10_1093_infdis_jiz030 crossref_primary_10_3390_brainsci8100190 crossref_primary_10_1002_glia_23568 crossref_primary_10_1093_infdis_jiz031 crossref_primary_10_1016_S2352_3018_20_30107_7 crossref_primary_10_1002_cti2_1318 crossref_primary_10_1093_infdis_jiaa765 crossref_primary_10_1007_s11904_018_0412_1 crossref_primary_10_1016_j_ebiom_2022_103917 crossref_primary_10_1093_cid_cix645 crossref_primary_10_1097_QAD_0000000000002925 crossref_primary_10_1016_S2055_6640_20_30236_3 crossref_primary_10_1172_JCI127413 crossref_primary_10_1371_journal_ppat_1006538 crossref_primary_10_1007_s41999_018_0145_0 crossref_primary_10_1007_s00415_017_8503_2 crossref_primary_10_1002_jcla_23673 crossref_primary_10_1007_s11481_023_10086_7 crossref_primary_10_1172_jci_insight_160267 crossref_primary_10_1111_hiv_13411 crossref_primary_10_3389_fnagi_2019_00187 crossref_primary_10_1097_QAD_0000000000002251 crossref_primary_10_3851_IMP3140 crossref_primary_10_1007_s11904_018_0375_2 crossref_primary_10_1097_MD_0000000000020516 |
Cites_doi | 10.1371/journal.pone.0046178 10.1093/cid/ciq041 10.1097/QAD.0b013e3283354a7b 10.1212/01.wnl.0000278457.55877.eb 10.1007/s00415-012-6688-y 10.1007/BF00180282 10.1093/infdis/174.2.294 10.1007/s11481-006-9035-1 10.1016/S0006-8993(03)03219-0 10.1097/QAI.0b013e31815ace97 10.1046/j.1471-4159.1996.67052013.x 10.1212/01.wnl.0000277635.05973.55 10.1097/QAI.0000000000000458 10.1186/1742-6405-7-15 10.1212/WNL.52.5.1090 10.1186/1471-2334-11-356 10.1212/WNL.0000000000000492 10.1212/WNL.0b013e318200d727 10.1371/journal.pone.0088591 10.1080/13803395.2010.535504 10.1212/01.WNL.0000287431.88658.8b 10.1097/QAD.0000000000000400 10.1086/523648 10.1007/s13365-011-0021-x 10.1080/13803390490510031 10.1371/journal.pone.0116081 10.1186/1742-2094-10-62 10.1080/13854046.2012.694479 10.1186/1741-7015-9-138 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2016 Public Library of Science 2016 Edén et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Edén et al 2016 Edén et al |
Copyright_xml | – notice: COPYRIGHT 2016 Public Library of Science – notice: 2016 Edén et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Edén et al 2016 Edén et al |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM AAOVB ADTPV AOWAS D8T F1U ZZAVC ABBSD F1S DOA |
DOI | 10.1371/journal.pone.0157160 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Göteborgs universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Göteborgs universitet SwePub Articles full text SWEPUB Chalmers tekniska högskola full text SWEPUB Chalmers tekniska högskola DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | Increased Immune Activation in HIV-1 Patients with HAND |
EISSN | 1932-6203 |
EndPage | e0157160 |
ExternalDocumentID | 1796245397 oai_doaj_org_article_76e001bde3664fa9963c57abd598f660 oai_research_chalmers_se_19a169f8_1107_4a47_8dc1_88b430e184a4 oai_gup_ub_gu_se_240034 PMC4905676 4088094871 A455013469 27295036 10_1371_journal_pone_0157160 |
Genre | Journal Article |
GeographicLocations | United States San Francisco California Sweden California United States--US |
GeographicLocations_xml | – name: United States – name: San Francisco California – name: California – name: United States--US – name: Sweden |
GrantInformation_xml | – fundername: NINDS NIH HHS grantid: R01 NS094067 – fundername: NIMH NIH HHS grantid: K24 MH097673 – fundername: NIMH NIH HHS grantid: HHSN271201000036C – fundername: NIMH NIH HHS grantid: P30 MH062512 – fundername: NIMH NIH HHS grantid: U24 MH100928 – fundername: NIDA NIH HHS grantid: P50 DA026306 – fundername: NIMH NIH HHS grantid: R01 MH107345 – fundername: NIMH NIH HHS grantid: N01 MH022005 – fundername: ; – fundername: ; grantid: ALFGBG-430271 – fundername: ; grantid: 2013-2546 – fundername: ; grantid: K2011-58P-20931-01-4 – fundername: ; grantid: ALFGBG-441051 – fundername: ; grantid: N01 MH22005 – fundername: ; grantid: K2010-63P-21562-01-4 – fundername: ; grantid: U24 MH100928 – fundername: ; grantid: K2011-61X-20401-05-6 – fundername: ; grantid: P30 MH62512 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM AAOVB ADTPV AOWAS D8T F1U ZZAVC ABBSD F1S PUEGO - 02 AAPBV ABPTK ADACO BBAFP KM |
ID | FETCH-LOGICAL-c839t-ed7f1ce1b5a37ed261e306ca3ac56c1cb1a5a709f922dcc7f1424ccfb87ecf5f3 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Fri Nov 26 17:13:06 EST 2021 Wed Aug 27 01:19:11 EDT 2025 Thu Aug 21 06:57:47 EDT 2025 Thu Aug 21 06:38:54 EDT 2025 Thu Aug 21 18:10:00 EDT 2025 Fri Jul 11 05:35:04 EDT 2025 Thu Jul 10 17:41:24 EDT 2025 Fri Jul 25 10:23:19 EDT 2025 Tue Jun 17 20:58:03 EDT 2025 Tue Jun 10 20:27:33 EDT 2025 Fri Jun 27 03:30:41 EDT 2025 Fri Jun 27 04:57:30 EDT 2025 Thu May 22 21:22:04 EDT 2025 Mon Jul 21 06:03:59 EDT 2025 Tue Jul 01 02:21:18 EDT 2025 Thu Apr 24 23:08:02 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c839t-ed7f1ce1b5a37ed261e306ca3ac56c1cb1a5a709f922dcc7f1424ccfb87ecf5f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have read the journal's policy and have the following competing interests. AE reports receiving travel grants from Gilead and BMS, and lecture honoraria from AbbVie. MG reports receiving honoraria as speaker and/or advisor from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen-Cilag, and Merck. HZ is co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Holding-based platform company at the University of Gothenburg. Funds to support research projects have been paid to UC San Diego on behalf of SLL by Abbvie, Gilead Sciences, Merck & Co., and ViiV Healthcare. Honoraria have also been paid to SLL for educational lectures (Abbvie, Janssen) or advisory boards (Cipla, Janssen, Merck & Co., and ViiV Healthcare). RWP reports receiving honoraria as speaker and/or advisor from Gilead, Merck. All other authors declare no conflict of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Conceived and designed the experiments: MG RWP. Performed the experiments: D. Fuchs HZ. Analyzed the data: AE MG SN. Wrote the paper: AE TDM RKH SN HZ D. Fuchs D. Franklin RWP IG SLL MG. Designed, performed, and coordinated the parent study (CHARTER) as well as the substudy (the NIMH AIDS Research Center (ARC) Biomarker project): IG RKH SLL TDM D. Franklin. Reviewed and identified the cases for the project: SLL TDM D. Franklin. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0157160 |
PMID | 27295036 |
PQID | 1796245397 |
PQPubID | 1436336 |
ParticipantIDs | plos_journals_1796245397 doaj_primary_oai_doaj_org_article_76e001bde3664fa9963c57abd598f660 swepub_primary_oai_research_chalmers_se_19a169f8_1107_4a47_8dc1_88b430e184a4 swepub_primary_oai_gup_ub_gu_se_240034 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4905676 proquest_miscellaneous_1808685231 proquest_miscellaneous_1797253530 proquest_journals_1796245397 gale_infotracmisc_A455013469 gale_infotracacademiconefile_A455013469 gale_incontextgauss_ISR_A455013469 gale_incontextgauss_IOV_A455013469 gale_healthsolutions_A455013469 pubmed_primary_27295036 crossref_citationtrail_10_1371_journal_pone_0157160 crossref_primary_10_1371_journal_pone_0157160 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-06-13 |
PublicationDateYYYYMMDD | 2016-06-13 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationTitleAlternate | PLoS One |
PublicationYear | 2016 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | FR Sattler (ref31) 2015; 68 BJ Brew (ref24) 1996; 174 A Antinori (ref3) 2007; 69 Krut J Jessen (ref12) 2014; 9 LE Rosengren (ref9) 1996; 67 LA Cysique (ref20) 2011; 33 K Blackstone (ref18) 2012; 26 RK Heaton (ref2) 2010; 75 RK Heaton (ref21) 2014 RW Price (ref7) 2007; 69 LE Rosengren (ref10) 1999; 52 A Yilmaz (ref29) 2008; 47 S Simioni (ref4) 2010; 24 BB Gelman (ref25) 2012; 7 C Torti (ref16) 2011; 9 J Peterson (ref27) 2014; 9 A Eden (ref13) 2007; 196 A Mellgren (ref26) 2007; 69 FX Lescure (ref1) 2011; 52 JJ Krut (ref23) 2013; 260 LA Cysique (ref5) 2011; 17 JR Bogner (ref28) 1992; 70 CL Carey (ref19) 2004; 26 L Hagberg (ref22) 2010; 7 M Gisslen (ref6) 2007; 2 A Yilmaz (ref14) 2013; 10 S Abdulle (ref11) 2007 V Dahl (ref30) 2014; 28 N Norgren (ref8) 2003; 987 M Gisslen (ref15) 2011; 11 I Grant (ref17) 2014; 82 |
References_xml | – volume: 7 start-page: e46178 issue: 9 year: 2012 ident: ref25 article-title: The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment publication-title: PLoS One doi: 10.1371/journal.pone.0046178 – volume: 52 start-page: 235 issue: 2 year: 2011 ident: ref1 article-title: Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study publication-title: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America doi: 10.1093/cid/ciq041 – volume: 24 start-page: 1243 issue: 9 year: 2010 ident: ref4 article-title: Cognitive dysfunction in HIV patients despite long-standing suppression of viremia publication-title: AIDS (London, England) doi: 10.1097/QAD.0b013e3283354a7b – volume: 69 start-page: 1781 issue: 18 year: 2007 ident: ref7 article-title: Biomarkers of HIV-1 CNS infection and injury publication-title: Neurology doi: 10.1212/01.wnl.0000278457.55877.eb – volume: 260 start-page: 620 issue: 2 year: 2013 ident: ref23 article-title: Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections publication-title: Journal of neurology doi: 10.1007/s00415-012-6688-y – volume: 70 start-page: 665 issue: 8 year: 1992 ident: ref28 article-title: Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection publication-title: The Clinical investigator doi: 10.1007/BF00180282 – volume: 174 start-page: 294 issue: 2 year: 1996 ident: ref24 article-title: Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin publication-title: The Journal of infectious diseases doi: 10.1093/infdis/174.2.294 – volume: 2 start-page: 112 issue: 1 year: 2007 ident: ref6 article-title: Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers publication-title: Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology doi: 10.1007/s11481-006-9035-1 – volume: 987 start-page: 25 issue: 1 year: 2003 ident: ref8 article-title: Elevated neurofilament levels in neurological diseases publication-title: Brain Res doi: 10.1016/S0006-8993(03)03219-0 – volume: 47 start-page: 168 issue: 2 year: 2008 ident: ref29 article-title: Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy publication-title: Journal of acquired immune deficiency syndromes (1999) doi: 10.1097/QAI.0b013e31815ace97 – volume: 67 start-page: 2013 issue: 5 year: 1996 ident: ref9 article-title: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF publication-title: Journal of neurochemistry doi: 10.1046/j.1471-4159.1996.67052013.x – volume: 69 start-page: 1536 issue: 15 year: 2007 ident: ref26 article-title: Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection publication-title: Neurology doi: 10.1212/01.wnl.0000277635.05973.55 – volume: 68 start-page: 281 issue: 3 year: 2015 ident: ref31 article-title: Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation publication-title: Journal of acquired immune deficiency syndromes (1999) doi: 10.1097/QAI.0000000000000458 – volume: 7 start-page: 15 year: 2010 ident: ref22 article-title: Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection publication-title: AIDS research and therapy doi: 10.1186/1742-6405-7-15 – volume: 52 start-page: 1090 issue: 5 year: 1999 ident: ref10 article-title: Neurofilament protein levels in CSF are increased in dementia publication-title: Neurology doi: 10.1212/WNL.52.5.1090 – volume: 11 start-page: 356 year: 2011 ident: ref15 article-title: The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? publication-title: BMC infectious diseases doi: 10.1186/1471-2334-11-356 – volume: 82 start-page: 2055 issue: 23 year: 2014 ident: ref17 article-title: Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline publication-title: Neurology doi: 10.1212/WNL.0000000000000492 – volume: 75 start-page: 2087 issue: 23 year: 2010 ident: ref2 article-title: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study publication-title: Neurology doi: 10.1212/WNL.0b013e318200d727 – volume: 9 start-page: e88591 issue: 2 year: 2014 ident: ref12 article-title: Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients publication-title: PLoS One doi: 10.1371/journal.pone.0088591 – volume: 33 start-page: 505 issue: 5 year: 2011 ident: ref20 article-title: Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change publication-title: Journal of clinical and experimental neuropsychology doi: 10.1080/13803395.2010.535504 – volume: 69 start-page: 1789 issue: 18 year: 2007 ident: ref3 article-title: Updated research nosology for HIV-associated neurocognitive disorders publication-title: Neurology doi: 10.1212/01.WNL.0000287431.88658.8b – volume: 28 start-page: 2251 issue: 15 year: 2014 ident: ref30 article-title: Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation publication-title: AIDS (London, England) doi: 10.1097/QAD.0000000000000400 – volume: 196 start-page: 1779 issue: 12 year: 2007 ident: ref13 article-title: Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy publication-title: The Journal of infectious diseases doi: 10.1086/523648 – volume: 17 start-page: 176 issue: 2 year: 2011 ident: ref5 article-title: Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression publication-title: Journal of neurovirology doi: 10.1007/s13365-011-0021-x – volume: 26 start-page: 307 issue: 3 year: 2004 ident: ref19 article-title: Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection publication-title: Journal of clinical and experimental neuropsychology doi: 10.1080/13803390490510031 – year: 2014 ident: ref21 article-title: Neurocognitive change in the era of HIV combination antiretroviral therapy: A longitudinal CHARTER Study publication-title: Clinical infectious diseases: an official publication of the Infectious Diseases Society of America – volume: 9 start-page: e116081 issue: 12 year: 2014 ident: ref27 article-title: Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection publication-title: PLoS One doi: 10.1371/journal.pone.0116081 – volume: 10 start-page: 62 year: 2013 ident: ref14 article-title: Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy publication-title: Journal of neuroinflammation doi: 10.1186/1742-2094-10-62 – volume: 26 start-page: 894 issue: 6 year: 2012 ident: ref18 article-title: Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings publication-title: The Clinical neuropsychologist doi: 10.1080/13854046.2012.694479 – year: 2007 ident: ref11 article-title: CSF neurofilament protein (NFL)—a marker of active HIV-related neurodegeneration publication-title: Journal of neurology – volume: 9 start-page: 138 year: 2011 ident: ref16 article-title: Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction? publication-title: BMC medicine doi: 10.1186/1741-7015-9-138 |
SSID | ssj0053866 |
Score | 2.4951446 |
Snippet | Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in patients... Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in... OBJECTIVEAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in... ObjectiveAlthough milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in... Objective Although milder forms of HIV-associated neurocognitive disorder (HAND) remain prevalent, a correlation to neuronal injury has not been established in... |
SourceID | plos doaj swepub pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e0157160 |
SubjectTerms | Acquired immune deficiency syndrome Activation Adult AIDS AIDS Dementia Complex - cerebrospinal fluid AIDS Dementia Complex - drug therapy AIDS Dementia Complex - immunology Analysis Anti-Retroviral Agents - therapeutic use antiretroviral Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Biology and Life Sciences Biomarkers Biomarkers - cerebrospinal fluid Brain research Care and treatment Central nervous system Cerebrospinal fluid cerebrospinal-fluid neopterin Cognition Cognitive ability Correlation csf deficit scores Dementia disorders Dosage and administration Drug therapy Drug use Female Health aspects Highly active antiretroviral therapy HIV HIV-1 - drug effects HIV-1 - immunology hiv-1 infection Human immunodeficiency virus Human immunodeficiency virus 1 Humans Immune response Impairment Infections Infectious diseases Infectious Medicine Infektionsmedicin Lentivirus Longitudinal Studies Male Medicine and Health Sciences Middle Aged Neopterin Neopterin - cerebrospinal fluid Neopterin - immunology neurofilament protein Neurofilament Proteins - cerebrospinal fluid Neurofilament Proteins - immunology Neurology Neuropsychology Patients prevalence Psychiatry Retroviridae Social Sciences Studies Therapy |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZQT1wQy2sDCwSEeByyG8fPHAti1SJeArbam-XYTlupSqtNe-DfM5OkEREVy4Fj7RlLmRmPZ9yZz4S8kCEXuhAaIjddJDyjPLE5DYnzcBo4ASewx97hT5_l5IJ_uBSXvz31hTVhLTxwK7gzJQN40sIHJiUvLYTnzAllCy9yXUrZZOtw5u2TqdYHwy6WsmuUY4qedXo53ayrcAoHICQJ6eAgavD6e6882qzW9aGQ88_KyQG-aHMmnd8mt7pgMh63H3FEboTqDjnqtmsdv-4wpd_cJVvwA1h-Hnw8xTUh7APlxFPsDgnx2O0fOYuXVTxbAs_qZ4wPfjbQ4j6eTGcJBU6s_YCfX1sw1jrGW9y4wffoy5BgzY1dXuGl4z1ycf7-x7tJ0j24kDiIk7ZJ8KqkLtBCWKYCaIsGyCicZRa05qgrqBVWpXmZZ5l3Doh5xp0rC62CK0XJ7pNRBSI-JnEpQ0hd6i0EUBy0X2hhQy6950Ixm4mIsL30jevQyPFRjJVp_mJTkJW0MjSoM9PpLCJJz7Vp0TiuoX-Liu1pEUu7GQALM52FmessLCJP0SxM25jaewQzxoZwyrjMI_K8oUA8jQoLduZ2V9dm-mX2D0Tfvw2IXnVE5RrE4WzXJAHfhDhdA8qTASV4BTeYPkYj3kulNuB4ZcYFhJ_AuTfsw9PP-mlcFIvwqrDeNTQqE0yw9C80GnJkLSBriMiDdq_00s8gkRMQMUVEDXbRQD3DmWq5aCDPeQ6BugLOl-1-G7DMdxsDQ_OdqYPBmmjGI_LxAGGHn7UwbtE8TlQjA80tlXmpDd6EGG65Mto7arQuOEsD1TD08H_Y0SNyE6JtiXWGlJ2Q0fZqFx5DRLstnjTO6xebkKGy priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZguXBBLK_tskBAiMchu3X8zAktiNUW8RKwVW-WYzttpSotTXvg3zOTuEERq4Vj7RlLnfG8nPFnQp7LkAtdCA2Zmy5SnlGe2pyG1HmIBk5ABPZ4d_jTZ3l-wT9MxCQeuNWxrXLnExtH7ZcOz8hPYOPIjAsIn29WP1N8NQq_rsYnNK6TGwhdhi1datIVXGDLUsbrckzRk6id49WyCscQBqFUGPbCUYPa3_nmvdViWV-WeP7dP9lDGW0i09ltciumlMlpuwf2ybVQ3SH70Wjr5FVEln59l2zAG2ATevDJCNeE5A9UlIzwjkhITt3uqbNkXiXjOfAsfiX47GcDMO6T89E4pcCJHSDw82sLyVoneJabNCgfXTMSrLmy8zUePd4jF2fvf7w7T-OzC6mDbGmTBq9K6gIthGUqgM5ogLrCWWZBd466glph1TAv8yzzzgExz7hzZaFVcKUo2X2yV4GID0hSyhCGbugtpFEc9kChhQ259J4LxWwmBoTtpG9cxCTHpzEWpvnQpqA2aWVoUGcm6mxA0o5r1WJy_IP-LSq2o0VE7WZguZ6aaKBGyQARu_CBSclLC2Ugc0LZwotclxIXeYLbwrTXUzu_YE7xWjhlXOYD8qyhQFSNCtt2pnZb12b0ZfwfRN-_9YheRqJyCeJwNl6VgP-EaF09yqMeJfgG15s-wE28k0pt_lgRcO429uXTT7tpXBRb8aqw3DY0KhNMsOEVNBoqZS2gdhiQB62tdNLPoJwTkDcNiOpZUU89_ZlqPmuAz3kO6boCzhetvfVYptuVgaHp1tTBYGc04wPy8RLCiKI1M27WPFFUIwPNLZV5qQ2ehxhuuTLaO2q0LjgbBqph6PBqkT0kNyGblthHSNkR2dust-ERZKyb4nHjln4DbLiZdQ priority: 102 providerName: ProQuest |
Title | Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27295036 https://www.proquest.com/docview/1796245397 https://www.proquest.com/docview/1797253530 https://www.proquest.com/docview/1808685231 https://pubmed.ncbi.nlm.nih.gov/PMC4905676 https://gup.ub.gu.se/publication/240034 https://research.chalmers.se/publication/240034 https://doaj.org/article/76e001bde3664fa9963c57abd598f660 http://dx.doi.org/10.1371/journal.pone.0157160 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytMEpAiI-HTHVsx84DQt20sSI2psGmvlmO43SVqrQ0rcRe-Nu5c9JIEWXwEqnxnaXe-Xx3zvl3hLyOXSJUKhREbioNeUR5aBLqQpuBN7ACPHCGd4dPz-KTS_55JEZbZN2ztRZguTG1w35Sl4vp_s8fNx_B4D_4rg2Srpn257PC7YN7gxQAkvht8E0STfWUN98VwLr910uMWsI46rP6Mt3fZmk5K4_p3-zcnfl0Vm4KS_-srmxhkHq_dXyf3KsDzmBQrZAdsuWKB2SnNukyeFfjTr9_SJawV2CJusuCIc4JoSEoMBjiDRIXDOy6EVowKYKrCfBMbwJsCurhx7PgZHgVUuDE-hD4eV4BtpYBnvQGHgOkKVWCOedmssCDyUfk8vjo--FJWDdlCC3EUsvQZTKn1tFUGCYdaJQ6yDqsYQY0a6lNqRFG9pM8iaLMWiDmEbc2T5V0Nhc5e0w6BYh4lwR57Fzf9jMDQRaHFZIqYVwSZxkXkplIdAlbS1_bGrEcG2dMtf8MJyFzqWSoUWe61lmXhA3XvELs-Af9ASq2oUW8bf9ithjr2ny1jB348zRzLI55biBJZFZIk2YiUXmMk7zAZaGry6vNrqEHeGmcMh4nXfLKUyDmRoFFPWOzKks9_Hr1H0TfLlpEb2uifAbisKa-SAH_CbG8WpR7LUrYOWxreBcX8VoqpYbNOY64gBAVONcLe_Pwy2YYJ8VCvcLNVp5GRoIJ1r-FRkEerQRkFl3ypLKVRvoRJHsCoqoukS0raqmnPVJMrj0sOk8gmJfA-aaytxbLeDXX8Gq80qXTWDfNeJd82UBYY2xda3vtGxiVyEATQ-MkVxpPSzQ3XGqVWaqVSjnrO6rg1dPbhf2M3IVYO8YqQ8r2SGe5WLnnEM8u0x65I0cSnuqQ4vP4U49sHxydnV_0_AlRz29h-Px19Bv6KKcQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbtQw0CrlgSdEubpQqEGcD2nj-EoeECpHtUsPELRV34zjONuVquzS7Ar1p_hGZnKhiKrw0seNZ6zszHgOZw5CnimfyDiVMXhucRqIiInAJswHLgNr4CRY4Axrh_f21fBQfDqWx0vkV1sLg2mVrU6sFHU2dXhHvgmCoyIhwXy-nf0IcGoUfl1tR2jUYrHjz39CyFa-GX0A_j6Pou2PB--HQTNVIHDgDMwDn-mcOc9Sabn28ErMg9vsLLfwao65lFlpdZjkSRRlzgGwiIRzeRpr73KZc9j3GrkOhjfEE6WPuwAPdIdSTXke12yzkYaN2bTwG2B2ITQJe-avmhLQ2YLl2em0vMjR_Ttfs9fVtLKE27fIzcaFpVu1zK2QJV_cJiuNkijpq6aT9es7ZA7aB5PefUZHuCc4myASdIQ1KZ5uuXa0Gp0U9GgCOKfnFMeMVg3NMzocHQUMMDHjBH5-qVvAlhTvjmnVVaRLfoI9Z3Zyhledd8nhlTDkHlkugMSrhObK-9CFmQW3TYDMpbG0PlFZJqTmNpIDwlvqG9f0QMdRHKem-rCnIRaqaWiQZ6bh2YAEHdas7gHyD_h3yNgOFjt4Vw-mZ2PTKASjlQcPIc08V0rkFsJO7qS2aSaTOFe4yTqKhanLYTs9ZLawDJ1xoZIBeVpBYBePAtOExnZRlmb0-eg_gL597QG9bIDyKZDD2aY0A_4TdgfrQa71IEEXud7yKgpxS5XS_Dm1gNkK9sXLT7pl3BRT_wo_XVQwOpJc8vASmBgi81hCrDIg9-uz0lE_gvBRgp82ILp3inrs6a8Uk5Oq0bpIIDzQgPmiPm89lPFiZuDReGFKbzATm4sB2b0AsOnadWLcSTUSqUQEllimkjw2eP9ihBXaxJljJo5TwUPPYnj04HKSrZMbw4O9XbM72t95iPdNYZOZukaW52cL_wi85Xn6uFJRlHy_ap34G8nC2Pg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3ZbtNAcFWChHhBlKuBQg3ifHCb9Z5-QKhQqoaWUlFa9W1Zr9dppMgJdSLUX-PrmPGFLKrCSx_jnVk5M7NzrOcg5Ln0sdCJ0OC56STkEeWhjakPXQrWwAmwwCnWDn_elztH_NOJOFkiv5paGEyrbHRiqajTqcM78g0QHBlxAeZzI6vTIg62tt_NfoQ4QQq_tDbjNCoR2fXnPyF8K94Ot4DXL6Jo--O3DzthPWEgdOAYzEOfqow6TxNhmfLwetSDC-0ss_CajrqEWmHVIM7iKEqdA2AeceeyRCvvMpEx2Pcaua6YoHjG1Ekb7IEekbIu1WOKbtSSsT6b5n4dTDCEKYOOKSwnBrR2oTebTIuLnN6_czc7HU5Lq7h9m9yq3dlgs5K_ZbLk8ztkuVYYRfC67mr95i6ZgybCBHifBkPcExxPEI9giPUpPth0zZi1YJwHx2PAmZwHOHK0bG6eBjvD45ACJmafwM-Dqh1sEeA9clB2GGkToWDPmR2f4bXnPXJ0JQy5T3o5kHiFBJn0fuAGqQUXjoP8JVpYH8s05UIxG4k-YQ31jav7oeNYjokpP_IpiIsqGhrkmal51idhizWr-oH8A_49MraFxW7e5YPp2cjUysEo6cFbSFLPpOSZhRCUOaFskopYZxI3WUOxMFVpbKuTzCaWpFPGZdwnz0oI7OiR49kY2UVRmOGX4_8AOvzaAXpVA2VTIIezdZkG_CfsFNaBXO1Agl5yneUVFOKGKoX5c4IBsxHsi5eftsu4KaYB5n66KGFUJJhgg0tgNETpWkDc0icPqrPSUj-CUFKAz9YnqnOKOuzpruTj07LpOo8hVFCA-bI6bx2U0WJm4NFoYQpvMCub8T7ZuwCw7uB1atxpOR6pQAQaWyrjTBu8izHccmV06qjROuFs4KmGRw8vJ9kauQHa0OwN93cfkZvg1EtMZ6RslfTmZwv_GBznefKk1FAB-X7VKvE32RPdOA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+Intrathecal+Immune+Activation+in+Virally+Suppressed+HIV-1+Infected+Patients+with+Neurocognitive+Impairment&rft.jtitle=PloS+one&rft.au=Ed%C3%A9n%2C+Arvid&rft.au=Marcotte%2C+Thomas+D&rft.au=Heaton%2C+Robert+K&rft.au=Nilsson%2C+Staffan&rft.date=2016-06-13&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=11&rft.issue=6&rft_id=info:doi/10.1371%2Fjournal.pone.0157160&rft.externalDocID=A455013469 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |